jpcrna, that has been my concern, although all conjecture, that many are using Cytosorb as a last resort, due to price. I have no evidence to base that on as it is just a concern. Data suggests that the technology works if utilized on the right patient at the right time. My hope is that the German data, when it arrives, will be the most "true," as they they have the most experience using Cytosorb based on sales numbers.
News 
Market Data 
Discover 
